Clinical improvement of a toddler with COVID-19 focal cerebral arteriopathy possibly due to intra-arterial nimodipine

Dekel Avital; Shlomi Peretz; Eliauh Perlow; Osnat Konen; Edna Inbar; Yarden Bulkowstein; Elhanan Nahum; Sharon Aharoni; Lital Cohen Vig; Yoram Nevo; Eitan Auriel; Rachel Straussberg

doi:10.1016/j.ejpn.2022.07.007

Clinical improvement of a toddler with COVID-19 focal cerebral arteriopathy possibly due to intra-arterial nimodipine

Dekel Avital, Shlomi Peretz, Eliauh Perlow, Osnat Konen, Edna Inbar, Yarden Bulkowstein, Elhanan Nahum, Sharon Aharoni, Lital Cohen Vig, Yoram Nevo, Eitan Auriel, Rachel Straussberg^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Pediatric stroke is considered an infrequent complication of COVID-19. Focal cerebral arteriopathy (FCA) is one of the most common causes of arterial ischemic stroke in a previously healthy child. The present report describes a toddler with FCA most likely induced by SARS-CoV-2 infection who showed significant clinical improvement that may be related to injection of intra-arterial nimodipine. To our knowledge, this is the first reported use of nimodipine in this setting.

Original language	English
Pages (from-to)	40-43
Number of pages	4
Journal	European Journal of Paediatric Neurology
Volume	40
DOIs	https://doi.org/10.1016/j.ejpn.2022.07.007
State	Published - Sep 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejpn.2022.07.007

Cite this

Avital, D., Peretz, S., Perlow, E., Konen, O., Inbar, E., Bulkowstein, Y., Nahum, E., Aharoni, S., Vig, L. C., Nevo, Y., Auriel, E., & Straussberg, R. (2022). Clinical improvement of a toddler with COVID-19 focal cerebral arteriopathy possibly due to intra-arterial nimodipine. European Journal of Paediatric Neurology, 40, 40-43. https://doi.org/10.1016/j.ejpn.2022.07.007

@article{04f9661e15324dbb9be21597434b9e2e,

title = "Clinical improvement of a toddler with COVID-19 focal cerebral arteriopathy possibly due to intra-arterial nimodipine",

abstract = "Pediatric stroke is considered an infrequent complication of COVID-19. Focal cerebral arteriopathy (FCA) is one of the most common causes of arterial ischemic stroke in a previously healthy child. The present report describes a toddler with FCA most likely induced by SARS-CoV-2 infection who showed significant clinical improvement that may be related to injection of intra-arterial nimodipine. To our knowledge, this is the first reported use of nimodipine in this setting.",

author = "Dekel Avital and Shlomi Peretz and Eliauh Perlow and Osnat Konen and Edna Inbar and Yarden Bulkowstein and Elhanan Nahum and Sharon Aharoni and Vig, {Lital Cohen} and Yoram Nevo and Eitan Auriel and Rachel Straussberg",

note = "Publisher Copyright: {\textcopyright} 2022 European Paediatric Neurology Society",

year = "2022",

month = sep,

doi = "10.1016/j.ejpn.2022.07.007",

language = "אנגלית",

volume = "40",

pages = "40--43",

journal = "European Journal of Paediatric Neurology",

issn = "1090-3798",

publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Clinical improvement of a toddler with COVID-19 focal cerebral arteriopathy possibly due to intra-arterial nimodipine

AU - Avital, Dekel

AU - Peretz, Shlomi

AU - Perlow, Eliauh

AU - Konen, Osnat

AU - Inbar, Edna

AU - Bulkowstein, Yarden

AU - Nahum, Elhanan

AU - Aharoni, Sharon

AU - Vig, Lital Cohen

AU - Nevo, Yoram

AU - Auriel, Eitan

AU - Straussberg, Rachel

PY - 2022/9

Y1 - 2022/9

N2 - Pediatric stroke is considered an infrequent complication of COVID-19. Focal cerebral arteriopathy (FCA) is one of the most common causes of arterial ischemic stroke in a previously healthy child. The present report describes a toddler with FCA most likely induced by SARS-CoV-2 infection who showed significant clinical improvement that may be related to injection of intra-arterial nimodipine. To our knowledge, this is the first reported use of nimodipine in this setting.

AB - Pediatric stroke is considered an infrequent complication of COVID-19. Focal cerebral arteriopathy (FCA) is one of the most common causes of arterial ischemic stroke in a previously healthy child. The present report describes a toddler with FCA most likely induced by SARS-CoV-2 infection who showed significant clinical improvement that may be related to injection of intra-arterial nimodipine. To our knowledge, this is the first reported use of nimodipine in this setting.

UR - http://www.scopus.com/inward/record.url?scp=85135533868&partnerID=8YFLogxK

U2 - 10.1016/j.ejpn.2022.07.007

DO - 10.1016/j.ejpn.2022.07.007

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 35933829

AN - SCOPUS:85135533868

SN - 1090-3798

VL - 40

SP - 40

EP - 43

JO - European Journal of Paediatric Neurology

JF - European Journal of Paediatric Neurology

ER -

Clinical improvement of a toddler with COVID-19 focal cerebral arteriopathy possibly due to intra-arterial nimodipine

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this